A generic alternative indicated for autoimmune care. Scientific action supports the regulation of immune responses to assist in managing joint inflammation and tissue stiffness.
A disease-modifying antirheumatic drug formulated to manage symptoms of rheumatoid arthritis and designed to alleviate joint damage and mitigate inflammation.
Mechanism of Action
It inhibits the enzyme dihydroorotate dehydrogenase, which is necessary for the production of pyrimidine. This reduces the proliferation of overactive immune cells responsible for joint inflammation and destruction.
Route of Administration
Oral
Onset Time
4–8 weeks
Duration
Very long-acting
Contraindications
Pregnancy, Severe liver disease, Severe immunodeficiency, Allergy to leflunomide
Severe Adverse Events
Severe liver injury, Bone marrow suppression, Serious infections, Severe skin reactions
Information for Arava is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
